Torrent Pharmaceuticals Statistics

Total Valuation

Torrent Pharmaceuticals has a market cap or net worth of INR 1.15 trillion. The enterprise value is 1.18 trillion.

Market Cap	1.15T
Enterprise Value	1.18T

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 21, 2024

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	96.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	68.05
EV / Sales	10.74
EV / EBITDA	33.77
EV / EBIT	43.75
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.59
Debt / EBITDA	1.16
Debt / FCF	n/a
Interest Coverage	8.32

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	14.99%
Revenue Per Employee	7.00M
Profits Per Employee	1.10M
Employee Count	15,718
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.70% in the last 52 weeks. The beta is 0.27, so Torrent Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+77.70%
50-Day Moving Average	3,351.34
200-Day Moving Average	2,793.94
Relative Strength Index (RSI)	52.74
Average Volume (20 Days)	264,602

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Torrent Pharmaceuticals had revenue of INR 109.96 billion and earned 17.35 billion in profits. Earnings per share was 51.27.

Revenue	109.96B
Gross Profit	82.66B
Operating Income	26.99B
Pretax Income	24.77B
Net Income	17.35B
EBITDA	34.74B
EBIT	26.99B
Earnings Per Share (EPS)	51.27

Full Income Statement

Balance Sheet

The company has 10.04 billion in cash and 40.39 billion in debt, giving a net cash position of -30.35 billion.

Cash & Cash Equivalents	10.04B
Total Debt	40.39B
Net Cash	-30.35B
Net Cash Per Share	n/a
Equity (Book Value)	68.56B
Book Value Per Share	202.58
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.17%, with operating and profit margins of 24.55% and 15.78%.

Gross Margin	75.17%
Operating Margin	24.55%
Pretax Margin	22.53%
Profit Margin	15.78%
EBITDA Margin	31.60%
EBIT Margin	24.55%
FCF Margin	n/a

Dividends & Yields

Torrent Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	27.27%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	-0.06%
Earnings Yield	1.51%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jul 8, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a